期刊文献+

2009-2011年某三甲医院鲍曼不动杆菌的耐药性分析 被引量:3

Analysis of drug resistance of Acinetobacter baumannii strains isolated from 2009 to 2011 in the third grade class A hospital
原文传递
导出
摘要 目的了解某三甲医院临床分离的鲍曼不动杆菌的分布及对各类抗菌药物的耐药性,以指导临床规范合理使用抗生素。方法收集常州市第一人民医院2009年1月至2011年12月临床分离的鲍曼不动杆菌,采用SPSS11.5统计软件统计分析鲍曼不动杆菌的检出率和耐药情况。结果2009-2011年共分离3 360株鲍曼不动杆菌,均占全院分离病原菌的前三位。最常见的分离部位为下呼吸道,主要来源于ICU、呼吸内科、神经外科和神经内科,该菌对亚胺培南、美罗培南和哌拉西林-他唑巴坦的耐药率在2009年分别是55.52%、56.53%和70.01%,2011年分别上升至79.70%、77.61%和79.76%,差异有统计学意义。结论鲍曼不动杆菌对多种抗菌药物耐药率明显增高,泛耐药鲍曼不动杆菌比例明显增加。应加强耐药性监测,规范抗菌素的使用,防止鲍曼不动杆菌的暴发流行。 Objective To investigate the distribution and drug resistance of Acinetobacter baumannii strains. Methods Clinical isolation and drug sensitivity test of A cine tob ac te r b aumannii in the First People's Hospital of Changzhou from Jan 2009 to Dec 2011 were retrospectively analyzed. Results A total of 3 360 A cinetobacter baumannii were isolated, which was one of the top three pathogenic bacteria from 2009 to 2011. Acinetobacter baumannii was primarily isolated from lower respiratory tracts of the patients main]y from department of intensive care unit (ICU), departments of respiratory, neurosurgery and neurology. The drug resistance rate to imipenem, meropenem and piperacillin-tazobactam increased from 55.52%, 56.53% and 70.01% in 2009 to 79.70%, 77.61% and 79.76% in 2011, respectively. The difference was statistically significant. Conclusion There were obviously increasing tread in the drug resistant rates ofAcinetobacter baumannii from 2009 to 2011. It is difficult to clear Acinetobacter baumannii strains. Resistance surveillance of Acinetobacter bauma^nii, standard use of antibiotics, disinfection and isolation work should be strengthened to prevent epidemic outbreaks.
出处 《热带医学杂志》 CAS 2013年第11期1375-1377,共3页 Journal of Tropical Medicine
关键词 鲍曼不动杆菌 抗菌素 耐药性 A cinetobacter baumannii antibiotic drug resistance
  • 相关文献

参考文献14

二级参考文献28

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2陶传敏,陈慧莉,刘义刚,陈文昭,范红.1998—2005年我院临床分离非发酵革兰阴性杆菌耐药性分析[J].中国感染与化疗杂志,2006,6(6):399-402. 被引量:14
  • 3石岩,刘大为,许大波,徐英春,陈民均,王辉.泛耐药鲍曼不动杆菌感染临床治疗初探[J].中国感染与化疗杂志,2007,7(1):34-37. 被引量:112
  • 4Wilcox Mark, Nathwani Dilip, Dryden Matthew. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections[J]. The Journal of Antimicrolbial Chemotheropy, 2004,53 ( 2 ) : 335 -344.
  • 5Moise Pamela A, Forrest Alan, Birmingham Mary C, et al. The efficacy and safety of linezolid as treatment for Staphylo coccus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin [J]. the iournal of antimicrolbial chemotheropy, 2002,50 (6):1017-1026.
  • 6Romanelli RM, Jesus LA, Clemente WT, et al. Outbreak of resistant Acinetobacter baurnannii-mcasures and proposal for prevention and control[J].Braz J Infect Dis, 2009, 13 (5) : 341-347.
  • 7Federico Perez, Andrea M Hujer, KristJne M Hujer, et al Global Challenge of Multidrug Resistant Acinetobacter bau mannii[J]. Antimicrob Agents Chemother, 2007,51(10) 3471- 3484.
  • 8Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baurnannii infections: epidemiology and management [J]. Curr Opin Infect Dis,2010,23(4):332- 339.
  • 9Mastoraki A, Douka E, Kriaras I, et al. Preventing strategy of multidrug resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units[J]. Eur J Cardiothorac Surg, 2008,33 (6) : 1086-1090.
  • 10Falagas M, Fragoulis K, Kasiakou S, et al. Nephrotoxicity of intravenous colistin:a prospective evaluation[J].Int J Antimicrob, 2005,26(6) :504-507.

共引文献179

同被引文献23

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部